Canvas Wealth Advisors LLC Purchases 19,377 Shares of The Clorox Company $CLX

Key Points

• Canvas Wealth Advisors LLC significantly increased its stake in The Clorox Company, acquiring an additional 19,377 shares, raising its ownership by 190.5% to hold 29,548 shares valued at approximately $3.76 million.
• Clorox reported $2.87 earnings per share (EPS) for the past quarter, exceeding analysts' expectations of $2.24, and set guidance for FY 2026 EPS between 5.950-6.30.
• The company declared a quarterly dividend of $1.24 per share, with an ex-dividend date of October 22nd, reflecting an annualized yield of 4.1%.

Canvas Wealth Advisors LLC boosted its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 190.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,548 shares of the company's stock after purchasing an additional 19,377 shares during the period. Clorox comprises 0.8% of Canvas Wealth Advisors LLC's holdings, making the stock its 29th biggest holding. Canvas Wealth Advisors LLC's holdings in Clorox were worth $3,760,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. American National Bank & Trust grew its holdings in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company's stock valued at $26,000 after purchasing an additional 89 shares during the last quarter. Ransom Advisory Ltd bought a new position in Clorox during the 1st quarter valued at about $35,000. GW&K Investment Management LLC grew its holdings in Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after purchasing an additional 208 shares during the last quarter. Roble Belko & Company Inc grew its holdings in Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after purchasing an additional 211 shares during the last quarter. Finally, IMA Advisory Services Inc. bought a new position in Clorox during the 1st quarter valued at about $58,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

Shares of CLX stock opened at $119.73 on Monday. The company's 50-day simple moving average is $121.61 and its two-hundred day simple moving average is $127.58. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company has a market capitalization of $14.58 billion, a P/E ratio of 18.36, a P/E/G ratio of 0.99 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same period last year, the firm earned $1.82 earnings per share. The company's quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. Clorox's dividend payout ratio (DPR) is currently 76.07%.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.63% of the company's stock.

Analyst Ratings Changes

CLX has been the topic of several analyst reports. Zacks Research upgraded shares of Clorox from a "strong sell" rating to a "hold" rating in a report on Monday, September 29th. Jefferies Financial Group dropped their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. Barclays dropped their target price on shares of Clorox from $118.00 to $112.00 and set an "underweight" rating on the stock in a research note on Tuesday, September 30th. The Goldman Sachs Group dropped their target price on shares of Clorox from $115.00 to $110.00 and set a "sell" rating on the stock in a research note on Wednesday, October 1st. Finally, TD Cowen dropped their target price on shares of Clorox from $120.00 to $117.00 and set a "hold" rating on the stock in a research note on Wednesday, October 1st. One research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat, Clorox currently has an average rating of "Reduce" and a consensus target price of $130.20.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.